Business Description
Sartorius Stedim Biotech SA
NAICS : 334510
SIC : 3844
ISIN : FR0013154002
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | 6.64 | |||||
Interest Coverage | 2.25 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.64 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | 9.9 | |||||
3-Year EPS without NRI Growth Rate | -9.9 | |||||
3-Year FCF Growth Rate | 1.9 | |||||
3-Year Book Growth Rate | 22.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 23.95 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 95.64 | |||||
9-Day RSI | 81.47 | |||||
14-Day RSI | 67.87 | |||||
3-1 Month Momentum % | -2.74 | |||||
6-1 Month Momentum % | -1.7 | |||||
12-1 Month Momentum % | -9.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.14 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.66 | |||||
Days Inventory | 261.62 | |||||
Days Sales Outstanding | 51.84 | |||||
Days Payable | 81.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.38 | |||||
3-Year Dividend Growth Rate | 61.8 | |||||
Forward Dividend Yield % | 0.38 | |||||
5-Year Yield-on-Cost % | 1.33 | |||||
Shareholder Yield % | -6.77 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.38 | |||||
Operating Margin % | 14.03 | |||||
Net Margin % | 5.04 | |||||
FCF Margin % | 20.51 | |||||
ROE % | 3.2 | |||||
ROA % | 1.31 | |||||
ROIC % | 2.93 | |||||
3-Year ROIIC % | -0.08 | |||||
ROC (Joel Greenblatt) % | 12.87 | |||||
ROCE % | 3.89 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 166.28 | |||||
Forward PE Ratio | 43.89 | |||||
PE Ratio without NRI | 166.28 | |||||
Shiller PE Ratio | 48.82 | |||||
Price-to-Owner-Earnings | 77.43 | |||||
PEG Ratio | 6.62 | |||||
PS Ratio | 8.25 | |||||
PB Ratio | 4.48 | |||||
Price-to-Free-Cash-Flow | 40.34 | |||||
Price-to-Operating-Cash-Flow | 28.57 | |||||
EV-to-EBIT | 71.22 | |||||
EV-to-Forward-EBIT | 34.01 | |||||
EV-to-EBITDA | 45.93 | |||||
EV-to-Forward-EBITDA | 27.1 | |||||
EV-to-Revenue | 9.48 | |||||
EV-to-Forward-Revenue | 7.03 | |||||
EV-to-FCF | 47.04 | |||||
Price-to-GF-Value | 0.68 | |||||
Price-to-Projected-FCF | 2.64 | |||||
Price-to-DCF (Earnings Based) | 4.38 | |||||
Price-to-DCF (FCF Based) | 1.1 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Price-to-Peter-Lynch-Fair-Value | 11.4 | |||||
Earnings Yield (Greenblatt) % | 1.4 | |||||
FCF Yield % | 2.44 | |||||
Forward Rate of Return (Yacktman) % | 15.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SDMHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sartorius Stedim Biotech SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,258.576 | ||
EPS (TTM) ($) | 1.198 | ||
Beta | 1.26 | ||
3-Year Sharpe Ratio | -0.63 | ||
3-Year Sortino Ratio | -0.82 | ||
Volatility % | 53.33 | ||
14-Day RSI | 67.87 | ||
14-Day ATR ($) | 2.273486 | ||
20-Day SMA ($) | 182.67402 | ||
12-1 Month Momentum % | -9.21 | ||
52-Week Range ($) | 158 - 299.86 | ||
Shares Outstanding (Mil) | 97.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sartorius Stedim Biotech SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sartorius Stedim Biotech SA Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Sartorius Stedim Biotech SA Frequently Asked Questions
What is Sartorius Stedim Biotech SA(SDMHF)'s stock price today?
When is next earnings date of Sartorius Stedim Biotech SA(SDMHF)?
Does Sartorius Stedim Biotech SA(SDMHF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |